Dr. Reddy’s launches Ibuprofen in the U.S. in January 2003. It is the first generic product to be marketed under the “Dr. Reddy’s” label in the US. The Ibuprofen launch is a significant event in Dr. Reddy's' endeavor to build a strong and sustainable US generics business.
Dr. Reddy’s releases its first “Corporate Safety, Health & Environment (SHE) Report for the year 2002 - 2003” on September 15, 2003 becoming the first Indian Pharma company to release a SHE report.
Click to read related memories
Dr. Reddy's. Worked with
Dr. Reddy's from April 2002- Nov 2008